Summary
Updated Aug 31, 2026
Alan R. Stewart is Director of Calidi Biotherapeutics, Inc. (CLDI). 5 SEC Form 4 filings on record going back to 2024, most recently on 19 August 2026. Most recent open-market trade: sold $209K of SSTI on 12 December 2024. Lifetime open-market sales: $209K.
Recent Transactions
2Every recent SEC Form 4 transaction Alan R. Stewart has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Alan R. Stewart go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Alan R. Stewart files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Allan Camaisa - $1K of CLDI open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Alan R. Stewart?
Alan R. Stewart is a corporate insider, tracked as Director of Calidi Biotherapeutics, Inc. (CLDI). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Alan R. Stewart submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Alan R. Stewart been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($209K) across all tracked filings.
Where can I see all of Alan R. Stewart's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Alan R. Stewart and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial